LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

Search

West Pharmaceutical Services Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

335.99 2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

325

Max

336.26

Pagrindiniai rodikliai

By Trading Economics

Pajamos

6.7M

139M

Pardavimai

40M

845M

P/E

Sektoriaus vid.

44.079

49.712

Pelnas, tenkantis vienai akcijai

2.13

Dividendų pajamingumas

0.26

Pelno marža

16.428

Darbuotojai

10,800

EBITDA

9M

219M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+13.13% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.26%

2.36%

Kitas uždarbis

2026-07-23

Kitas dividendų mokėjimo data

2026-08-05

Kita Ex Dividend data

2026-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.3B

23B

Ankstesnė atidarymo kaina

333.99

Ankstesnė uždarymo kaina

335.99

Naujienos nuotaikos

By Acuity

50%

50%

143 / 342 reitingas Healthcare

West Pharmaceutical Services Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat